Clinical Trials Directory

Trials / Unknown

UnknownNCT04794049

Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation

Oral Lactulose is Not Inferior to The Standard Bowel Preparation Regimen for Bowel Preparation Prior Colonoscopy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
800 (estimated)
Sponsor
First People's Hospital of Hangzhou · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Adequate quality of bowel preparation(BP) is essential for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG caused lower compliance to the regime and increased cost. Oral lactulose is a treatment for constipation. It tastes sweet and has no obvious gastrointestinal side effects. Previous study shows 200ml lactulose oral solution plus 2L water has been proven superior BP compared to 2L PEG. However, there is a lack of research describing bowel cleansing and colonoscopy outcomes using lactulose oral solution compared with the standard split dose of 4L PEG. Here we compared the use of a lactulose oral solution (300ml+1.5 L) with a PEG formulation (2 L) for colonoscopy preparation using the following metrics: quality of cleansing, colonoscopy outcomes, patient/physician satisfaction, and patient tolerability.

Conditions

Interventions

TypeNameDescription
DRUGLactuloseIn experiment cohort, patients do not use standard bowel preparation regimen, they totally drink 300ml lactulose.
DRUGPolyethylene Glycol (PEG)In control cohort, patients use the standard split-dose bowel preparation regimen,

Timeline

Start date
2021-05-01
Primary completion
2021-10-30
Completion
2021-12-31
First posted
2021-03-11
Last updated
2021-03-11

Source: ClinicalTrials.gov record NCT04794049. Inclusion in this directory is not an endorsement.